Engineering CAR T cells for enhanced efficacy and safety
Author:
Affiliation:
1. Institute of Engineering in Medicine, University of California, San Diego, La Jolla, California 92093, USA
2. Department of Bioengineering, University of California, San Diego, La Jolla, California 92093, USA
Funder
National Institutes of Health
Publisher
AIP Publishing
Subject
Biomedical Engineering,Biomaterials,Biophysics,Bioengineering
Link
https://aip.scitation.org/doi/pdf/10.1063/5.0073746
Reference170 articles.
1. Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias
3. Chimeric antigen receptor T cell therapy: 25years in the making
4. Going viral: chimeric antigen receptor T-cell therapy for hematological malignancies
5. CAR T‐cell therapy: Full speed ahead
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Enhanced non-viral gene delivery via calcium phosphate/DNA co-precipitates with low-voltage pulse electroporation in NK-92 cells for immunocellular therapy;APL Bioengineering;2024-08-06
2. The next frontier in immunotherapy: potential and challenges of CAR-macrophages;Experimental Hematology & Oncology;2024-08-05
3. Boosting CAR-T cell therapy with CRISPR technology;hLife;2024-08
4. Generation and Functional Verification of Hypoxia-sensitive Chimeric Antigen Receptor-T Cells;Journal of Visualized Experiments;2024-06-14
5. The role of CD4+ CAR T cells in cancer immunotherapy;Translational Cancer Research;2024-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3